Publication:
Lipopolysaccharide from nonvirulent Ara<sup>+</sup> Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara<sup>-</sup> clinical isolates

dc.contributor.authorNarisara Anuntagoolen_US
dc.contributor.authorPakamas Intachoteen_US
dc.contributor.authorVanaporn Wuthiekanunen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorStitaya Sirisinhaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-07-04T08:03:40Z
dc.date.available2018-07-04T08:03:40Z
dc.date.issued1998-04-21en_US
dc.description.abstractDifferent lines of evidence suggest that a discrepancy between the distribution of Burkholderia (Pseudomonas) pseudomallei in the environment and the distribution of the disease melioidosis is attributable, at least in part, to phenotypic differences between clinical and some environmental isolates. Two antigenically and biochemically distinct biotypes have been described, only one of which is virulent. In this study, lipopolysaccharides (LPSs) were extracted by the proteinase K digestion method from a total of 214 B. pseudomallei isolates, and their immunoreactivities with sera from patients with different clinical spectra and with other infections were evaluated. With the exception of 4 isolates from a total of 214 tested, the sodium dodecyl sulfate-polyacrylamide gel electrophoresis silver-staining profiles of the LPSs from the two biotypes showed identical ladder patterns that were typical for smooth LPSs from other gram-negative bacteria. The 210 isolates with typical LPS patterns (119 Ara- clinical, 13 Ara- soil, 70 Ara+ soil, and 8 reference National Type Culture Collection strains) also exhibited similar immunoblot profiles against pooled sera from patients with melioidosis and hyperimmune mouse sera. Concordant findings were noted in the indirect enzyme-linked immunosorbent assay with Ara- and Ara+ LPSs to coat the microtiter plates. The LPSs of the different B. pseudomallei biotypes appear antigenically indistinguishable. It is, therefore, unlikely that this component is related to the virulence and pathogenicity of B. pseudomallei.en_US
dc.identifier.citationClinical and Diagnostic Laboratory Immunology. Vol.5, No.2 (1998), 225-229en_US
dc.identifier.issn1071412Xen_US
dc.identifier.other2-s2.0-0031954681en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18306
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031954681&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleLipopolysaccharide from nonvirulent Ara<sup>+</sup> Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara<sup>-</sup> clinical isolatesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031954681&origin=inwarden_US

Files

Collections